ACLASTA is useful in treating high blood calcium levels caused due to cancer. It is a bisphosphonate. It functions by reducing the breakdown of bone. This decreases the amount of calcium that is released into the blood from bones as well as aids in lowering blood calcium level.
Aclasta is used to treats Paget’s disease and osteoporosis in postmenopausal women.
Aclasta contains zoledronic acid (sometimes called zoledronate). It belongs to a group of medicines called bisphosphonates. Zoledronic acid inhibits the release of calcium from bones.